Westport Asset Management Inc. recently acquired 10,000 shares of Gilead Sciences, Inc. (NASDAQ:GILD) valued at approximately $1.26 million, contributing to the 83.67% institutional ownership of the company. Analysts maintain a "Moderate Buy" consensus rating with an average price target of $158.04, reflecting a generally positive outlook. Gilead also reported strong quarterly revenue of $7.8 billion, a 10.6% year-over-year increase, and declared a quarterly dividend of $0.82.

Johnson Financial Group Inc. has acquired a new stake in Gilead Sciences, Inc., purchasing 16,791 shares valued at approximately $2.12 million. This investment comes amidst broad optimism from analysts, with a "Moderate Buy" consensus and an average target price of $158.04, following Gilead's reported quarterly revenue of $7.8 billion, exceeding expectations. The company also declared a quarterly dividend of $0.82 per share.